---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-006086"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2022-08-15T23:59:59+00:00"
generated_at: "2026-06-23T23:56:50.445942+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionexus Gene Lab replaces Chairman, CEO, and President in leadership reshuffle

## Summary
- Chairman Soo Kow Lai, CEO Chan Chong Wong, and President Chi Yuen Leong resigned effective Aug 12, 2022; no disagreement cited.
- Yeat Min Fong appointed Chairman, Sook Keng Yeoh CEO, Yee Meng Wong President, effective Aug 9, 2022.
- Each new officer receives $12,000 annual salary and 25,000 common shares under employment agreements.
- Fong has 15+ years in medical industry; Yeoh 41 years in management; Wong biochem background with 10+ years research.

## SEC filing metadata
- accession: 0001477932-22-006086
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2022-08-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-006086
- JSON: https://secwatch.observer/filing/0001477932-22-006086.json
- Plain text: https://secwatch.observer/filing/0001477932-22-006086.txt

## Key facts
- Executive change
  Soo Kow Lai resigned as Chairman at BioNexus Gene Lab Corp.
  - Action: resigned
  - Role: Chairman
  source text: On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- Executive change
  Yee Meng Wong was appointed as President at BioNexus Gene Lab Corp.
  - Action: appointed
  - Role: President
  source text: On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- Executive change
  Chan Chong Wong resigned as Chief Executive Officer at BioNexus Gene Lab Corp.
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- Executive change
  Chi Yuen Leong resigned as President at BioNexus Gene Lab Corp.
  - Action: resigned
  - Role: President
  source text: On August 9, 2022, Mr. Soo Kow Lai, the Chairman and director, Mr. Chan Chong Wong, the Chief Executive Officer and director, and Mr. Chi Yuen Leong, the President and director, notified Bionexus Gene Lab Corp (“the Company”) their desire to resign from their positions at the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- Executive change
  Sook Keng Yeoh was appointed as Chief Executive Officer at BioNexus Gene Lab Corp.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
- Executive change
  Yeat Min Fong was appointed as Chairman at BioNexus Gene Lab Corp.
  - Action: appointed
  - Role: Chairman
  source text: On August 9, 2022, the Board of Directors of the Company approved the appointments of Mr. Yeat Min Fong as the Chairman and director, Mr. Sook Keng Yeoh as the Chief Executive Officer and director, and Ms. Yee Meng Wong as the President and director, effective August 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.